nodes	percent_of_prediction	percent_of_DWPC	metapath
Sitaxentan—CYP2C9—Capecitabine—colon cancer	0.119	0.441	CbGbCtD
Sitaxentan—CYP2C9—Fluorouracil—colon cancer	0.0707	0.262	CbGbCtD
Sitaxentan—CYP3A4—Irinotecan—colon cancer	0.0428	0.158	CbGbCtD
Sitaxentan—CYP3A4—Vincristine—colon cancer	0.0374	0.139	CbGbCtD
Sitaxentan—Immune system disorder—Irinotecan—colon cancer	0.000867	0.00119	CcSEcCtD
Sitaxentan—Mediastinal disorder—Irinotecan—colon cancer	0.000865	0.00119	CcSEcCtD
Sitaxentan—Dehydration—Capecitabine—colon cancer	0.000864	0.00118	CcSEcCtD
Sitaxentan—Mental disorder—Vincristine—colon cancer	0.000864	0.00118	CcSEcCtD
Sitaxentan—Neoplasm—Methotrexate—colon cancer	0.000861	0.00118	CcSEcCtD
Sitaxentan—Liver function test abnormal—Capecitabine—colon cancer	0.000857	0.00117	CcSEcCtD
Sitaxentan—Dry skin—Capecitabine—colon cancer	0.000851	0.00117	CcSEcCtD
Sitaxentan—Alopecia—Irinotecan—colon cancer	0.000848	0.00116	CcSEcCtD
Sitaxentan—Orthostatic hypotension—Capecitabine—colon cancer	0.000848	0.00116	CcSEcCtD
Sitaxentan—Abdominal pain upper—Capecitabine—colon cancer	0.000848	0.00116	CcSEcCtD
Sitaxentan—Breast disorder—Capecitabine—colon cancer	0.000839	0.00115	CcSEcCtD
Sitaxentan—Aspartate aminotransferase increased—Capecitabine—colon cancer	0.000836	0.00115	CcSEcCtD
Sitaxentan—Muscular weakness—Capecitabine—colon cancer	0.000819	0.00112	CcSEcCtD
Sitaxentan—Alanine aminotransferase increased—Capecitabine—colon cancer	0.000819	0.00112	CcSEcCtD
Sitaxentan—Alopecia—Fluorouracil—colon cancer	0.000812	0.00111	CcSEcCtD
Sitaxentan—Muscle spasms—Irinotecan—colon cancer	0.000803	0.0011	CcSEcCtD
Sitaxentan—Asthma—Capecitabine—colon cancer	0.000803	0.0011	CcSEcCtD
Sitaxentan—Anaemia—Vincristine—colon cancer	0.000793	0.00109	CcSEcCtD
Sitaxentan—Agitation—Vincristine—colon cancer	0.000789	0.00108	CcSEcCtD
Sitaxentan—Angina pectoris—Capecitabine—colon cancer	0.000782	0.00107	CcSEcCtD
Sitaxentan—Ill-defined disorder—Irinotecan—colon cancer	0.000775	0.00106	CcSEcCtD
Sitaxentan—Anaemia—Irinotecan—colon cancer	0.000772	0.00106	CcSEcCtD
Sitaxentan—Bronchitis—Capecitabine—colon cancer	0.000772	0.00106	CcSEcCtD
Sitaxentan—Vertigo—Vincristine—colon cancer	0.000771	0.00106	CcSEcCtD
Sitaxentan—Abdominal discomfort—Capecitabine—colon cancer	0.000769	0.00105	CcSEcCtD
Sitaxentan—Hepatic failure—Methotrexate—colon cancer	0.000769	0.00105	CcSEcCtD
Sitaxentan—Leukopenia—Vincristine—colon cancer	0.000768	0.00105	CcSEcCtD
Sitaxentan—Pancytopenia—Capecitabine—colon cancer	0.000762	0.00104	CcSEcCtD
Sitaxentan—Malaise—Irinotecan—colon cancer	0.000754	0.00103	CcSEcCtD
Sitaxentan—Vertigo—Irinotecan—colon cancer	0.000751	0.00103	CcSEcCtD
Sitaxentan—Dysuria—Capecitabine—colon cancer	0.000751	0.00103	CcSEcCtD
Sitaxentan—Leukopenia—Irinotecan—colon cancer	0.000748	0.00102	CcSEcCtD
Sitaxentan—Anaemia—Fluorouracil—colon cancer	0.00074	0.00101	CcSEcCtD
Sitaxentan—Photosensitivity reaction—Capecitabine—colon cancer	0.000733	0.001	CcSEcCtD
Sitaxentan—Visual disturbance—Methotrexate—colon cancer	0.00073	0.001	CcSEcCtD
Sitaxentan—Weight decreased—Capecitabine—colon cancer	0.000726	0.000995	CcSEcCtD
Sitaxentan—Hyperglycaemia—Capecitabine—colon cancer	0.000724	0.000992	CcSEcCtD
Sitaxentan—Leukopenia—Fluorouracil—colon cancer	0.000716	0.000982	CcSEcCtD
Sitaxentan—Infestation NOS—Capecitabine—colon cancer	0.000716	0.000981	CcSEcCtD
Sitaxentan—Infestation—Capecitabine—colon cancer	0.000716	0.000981	CcSEcCtD
Sitaxentan—Acute coronary syndrome—Capecitabine—colon cancer	0.000705	0.000967	CcSEcCtD
Sitaxentan—Renal failure—Capecitabine—colon cancer	0.000703	0.000964	CcSEcCtD
Sitaxentan—Discomfort—Irinotecan—colon cancer	0.000703	0.000963	CcSEcCtD
Sitaxentan—Myocardial infarction—Capecitabine—colon cancer	0.000702	0.000961	CcSEcCtD
Sitaxentan—Oedema—Vincristine—colon cancer	0.0007	0.00096	CcSEcCtD
Sitaxentan—Jaundice—Capecitabine—colon cancer	0.000698	0.000956	CcSEcCtD
Sitaxentan—Stomatitis—Capecitabine—colon cancer	0.000698	0.000956	CcSEcCtD
Sitaxentan—Infection—Vincristine—colon cancer	0.000696	0.000953	CcSEcCtD
Sitaxentan—Conjunctivitis—Capecitabine—colon cancer	0.000696	0.000953	CcSEcCtD
Sitaxentan—Osteoarthritis—Methotrexate—colon cancer	0.000691	0.000947	CcSEcCtD
Sitaxentan—Confusional state—Irinotecan—colon cancer	0.000688	0.000942	CcSEcCtD
Sitaxentan—Nervous system disorder—Vincristine—colon cancer	0.000687	0.000941	CcSEcCtD
Sitaxentan—Thrombocytopenia—Vincristine—colon cancer	0.000686	0.000939	CcSEcCtD
Sitaxentan—Haematuria—Capecitabine—colon cancer	0.000682	0.000935	CcSEcCtD
Sitaxentan—Oedema—Irinotecan—colon cancer	0.000682	0.000934	CcSEcCtD
Sitaxentan—Chest pain—Fluorouracil—colon cancer	0.000681	0.000934	CcSEcCtD
Sitaxentan—Infection—Irinotecan—colon cancer	0.000678	0.000928	CcSEcCtD
Sitaxentan—Hepatobiliary disease—Capecitabine—colon cancer	0.000677	0.000927	CcSEcCtD
Sitaxentan—Epistaxis—Capecitabine—colon cancer	0.000675	0.000925	CcSEcCtD
Sitaxentan—Discomfort—Fluorouracil—colon cancer	0.000673	0.000922	CcSEcCtD
Sitaxentan—Nervous system disorder—Irinotecan—colon cancer	0.000669	0.000916	CcSEcCtD
Sitaxentan—Thrombocytopenia—Irinotecan—colon cancer	0.000668	0.000915	CcSEcCtD
Sitaxentan—Anorexia—Vincristine—colon cancer	0.000668	0.000915	CcSEcCtD
Sitaxentan—Confusional state—Fluorouracil—colon cancer	0.000659	0.000902	CcSEcCtD
Sitaxentan—Hypotension—Vincristine—colon cancer	0.000654	0.000897	CcSEcCtD
Sitaxentan—Bradycardia—Capecitabine—colon cancer	0.000654	0.000896	CcSEcCtD
Sitaxentan—Oedema—Fluorouracil—colon cancer	0.000653	0.000895	CcSEcCtD
Sitaxentan—Anorexia—Irinotecan—colon cancer	0.00065	0.000891	CcSEcCtD
Sitaxentan—Ataxia—Methotrexate—colon cancer	0.00065	0.000891	CcSEcCtD
Sitaxentan—Infection—Fluorouracil—colon cancer	0.000649	0.000889	CcSEcCtD
Sitaxentan—Haemoglobin—Capecitabine—colon cancer	0.000646	0.000885	CcSEcCtD
Sitaxentan—Rhinitis—Capecitabine—colon cancer	0.000644	0.000883	CcSEcCtD
Sitaxentan—Hepatitis—Capecitabine—colon cancer	0.000642	0.00088	CcSEcCtD
Sitaxentan—Haemorrhage—Capecitabine—colon cancer	0.000642	0.00088	CcSEcCtD
Sitaxentan—Nervous system disorder—Fluorouracil—colon cancer	0.000641	0.000878	CcSEcCtD
Sitaxentan—Thrombocytopenia—Fluorouracil—colon cancer	0.00064	0.000876	CcSEcCtD
Sitaxentan—Liver function test abnormal—Methotrexate—colon cancer	0.000638	0.000875	CcSEcCtD
Sitaxentan—Tachycardia—Fluorouracil—colon cancer	0.000637	0.000874	CcSEcCtD
Sitaxentan—Hypotension—Irinotecan—colon cancer	0.000637	0.000873	CcSEcCtD
Sitaxentan—Urinary tract disorder—Capecitabine—colon cancer	0.000634	0.000869	CcSEcCtD
Sitaxentan—Insomnia—Vincristine—colon cancer	0.000633	0.000868	CcSEcCtD
Sitaxentan—Oedema peripheral—Capecitabine—colon cancer	0.000633	0.000867	CcSEcCtD
Sitaxentan—Urethral disorder—Capecitabine—colon cancer	0.00063	0.000863	CcSEcCtD
Sitaxentan—Breast disorder—Methotrexate—colon cancer	0.000625	0.000856	CcSEcCtD
Sitaxentan—Anorexia—Fluorouracil—colon cancer	0.000623	0.000853	CcSEcCtD
Sitaxentan—Visual impairment—Capecitabine—colon cancer	0.000619	0.000848	CcSEcCtD
Sitaxentan—Insomnia—Irinotecan—colon cancer	0.000617	0.000845	CcSEcCtD
Sitaxentan—Hypotension—Fluorouracil—colon cancer	0.00061	0.000836	CcSEcCtD
Sitaxentan—Decreased appetite—Vincristine—colon cancer	0.000609	0.000834	CcSEcCtD
Sitaxentan—Somnolence—Irinotecan—colon cancer	0.000606	0.000831	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Vincristine—colon cancer	0.000605	0.000828	CcSEcCtD
Sitaxentan—Fatigue—Vincristine—colon cancer	0.000604	0.000827	CcSEcCtD
Sitaxentan—Eye disorder—Capecitabine—colon cancer	0.0006	0.000823	CcSEcCtD
Sitaxentan—Dyspepsia—Irinotecan—colon cancer	0.0006	0.000823	CcSEcCtD
Sitaxentan—Tinnitus—Capecitabine—colon cancer	0.000599	0.000821	CcSEcCtD
Sitaxentan—Pain—Vincristine—colon cancer	0.000599	0.000821	CcSEcCtD
Sitaxentan—Constipation—Vincristine—colon cancer	0.000599	0.000821	CcSEcCtD
Sitaxentan—Asthma—Methotrexate—colon cancer	0.000598	0.000819	CcSEcCtD
Sitaxentan—Flushing—Capecitabine—colon cancer	0.000596	0.000817	CcSEcCtD
Sitaxentan—Cardiac disorder—Capecitabine—colon cancer	0.000596	0.000817	CcSEcCtD
Sitaxentan—Decreased appetite—Irinotecan—colon cancer	0.000593	0.000812	CcSEcCtD
Sitaxentan—Eosinophilia—Methotrexate—colon cancer	0.000592	0.000811	CcSEcCtD
Sitaxentan—Insomnia—Fluorouracil—colon cancer	0.000591	0.000809	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Irinotecan—colon cancer	0.000589	0.000807	CcSEcCtD
Sitaxentan—Fatigue—Irinotecan—colon cancer	0.000588	0.000806	CcSEcCtD
Sitaxentan—Pain—Irinotecan—colon cancer	0.000583	0.000799	CcSEcCtD
Sitaxentan—Constipation—Irinotecan—colon cancer	0.000583	0.000799	CcSEcCtD
Sitaxentan—Angiopathy—Capecitabine—colon cancer	0.000583	0.000799	CcSEcCtD
Sitaxentan—Somnolence—Fluorouracil—colon cancer	0.000581	0.000796	CcSEcCtD
Sitaxentan—Immune system disorder—Capecitabine—colon cancer	0.00058	0.000795	CcSEcCtD
Sitaxentan—Mediastinal disorder—Capecitabine—colon cancer	0.000579	0.000793	CcSEcCtD
Sitaxentan—Dyspepsia—Fluorouracil—colon cancer	0.000575	0.000788	CcSEcCtD
Sitaxentan—Abdominal discomfort—Methotrexate—colon cancer	0.000573	0.000785	CcSEcCtD
Sitaxentan—Decreased appetite—Fluorouracil—colon cancer	0.000568	0.000778	CcSEcCtD
Sitaxentan—Alopecia—Capecitabine—colon cancer	0.000568	0.000778	CcSEcCtD
Sitaxentan—Pancytopenia—Methotrexate—colon cancer	0.000567	0.000778	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000564	0.000773	CcSEcCtD
Sitaxentan—Mental disorder—Capecitabine—colon cancer	0.000563	0.000771	CcSEcCtD
Sitaxentan—Feeling abnormal—Irinotecan—colon cancer	0.000562	0.00077	CcSEcCtD
Sitaxentan—Malnutrition—Capecitabine—colon cancer	0.000559	0.000766	CcSEcCtD
Sitaxentan—Dysuria—Methotrexate—colon cancer	0.000559	0.000766	CcSEcCtD
Sitaxentan—Pain—Fluorouracil—colon cancer	0.000559	0.000765	CcSEcCtD
Sitaxentan—Body temperature increased—Vincristine—colon cancer	0.000554	0.000759	CcSEcCtD
Sitaxentan—Photosensitivity reaction—Methotrexate—colon cancer	0.000545	0.000747	CcSEcCtD
Sitaxentan—Body temperature increased—Irinotecan—colon cancer	0.000539	0.000739	CcSEcCtD
Sitaxentan—Feeling abnormal—Fluorouracil—colon cancer	0.000538	0.000738	CcSEcCtD
Sitaxentan—Muscle spasms—Capecitabine—colon cancer	0.000538	0.000737	CcSEcCtD
Sitaxentan—Infestation NOS—Methotrexate—colon cancer	0.000533	0.00073	CcSEcCtD
Sitaxentan—Infestation—Methotrexate—colon cancer	0.000533	0.00073	CcSEcCtD
Sitaxentan—Tremor—Capecitabine—colon cancer	0.000524	0.000718	CcSEcCtD
Sitaxentan—Renal failure—Methotrexate—colon cancer	0.000524	0.000718	CcSEcCtD
Sitaxentan—Stomatitis—Methotrexate—colon cancer	0.000519	0.000712	CcSEcCtD
Sitaxentan—Ill-defined disorder—Capecitabine—colon cancer	0.000519	0.000711	CcSEcCtD
Sitaxentan—Urticaria—Fluorouracil—colon cancer	0.000519	0.000711	CcSEcCtD
Sitaxentan—Conjunctivitis—Methotrexate—colon cancer	0.000518	0.00071	CcSEcCtD
Sitaxentan—Anaemia—Capecitabine—colon cancer	0.000517	0.000708	CcSEcCtD
Sitaxentan—Body temperature increased—Fluorouracil—colon cancer	0.000516	0.000708	CcSEcCtD
Sitaxentan—Hypersensitivity—Vincristine—colon cancer	0.000516	0.000707	CcSEcCtD
Sitaxentan—Haematuria—Methotrexate—colon cancer	0.000508	0.000696	CcSEcCtD
Sitaxentan—Malaise—Capecitabine—colon cancer	0.000504	0.000691	CcSEcCtD
Sitaxentan—Hepatobiliary disease—Methotrexate—colon cancer	0.000504	0.00069	CcSEcCtD
Sitaxentan—Epistaxis—Methotrexate—colon cancer	0.000503	0.000689	CcSEcCtD
Sitaxentan—Vertigo—Capecitabine—colon cancer	0.000502	0.000689	CcSEcCtD
Sitaxentan—Hypersensitivity—Irinotecan—colon cancer	0.000502	0.000688	CcSEcCtD
Sitaxentan—Asthenia—Vincristine—colon cancer	0.000502	0.000688	CcSEcCtD
Sitaxentan—Leukopenia—Capecitabine—colon cancer	0.000501	0.000686	CcSEcCtD
Sitaxentan—Asthenia—Irinotecan—colon cancer	0.000489	0.00067	CcSEcCtD
Sitaxentan—Hypersensitivity—Fluorouracil—colon cancer	0.000481	0.000659	CcSEcCtD
Sitaxentan—Haemoglobin—Methotrexate—colon cancer	0.000481	0.000659	CcSEcCtD
Sitaxentan—Diarrhoea—Vincristine—colon cancer	0.000479	0.000657	CcSEcCtD
Sitaxentan—Haemorrhage—Methotrexate—colon cancer	0.000478	0.000655	CcSEcCtD
Sitaxentan—Hepatitis—Methotrexate—colon cancer	0.000478	0.000655	CcSEcCtD
Sitaxentan—Chest pain—Capecitabine—colon cancer	0.000476	0.000652	CcSEcCtD
Sitaxentan—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000473	0.000648	CcSEcCtD
Sitaxentan—Urinary tract disorder—Methotrexate—colon cancer	0.000472	0.000647	CcSEcCtD
Sitaxentan—Discomfort—Capecitabine—colon cancer	0.00047	0.000645	CcSEcCtD
Sitaxentan—Urethral disorder—Methotrexate—colon cancer	0.000469	0.000642	CcSEcCtD
Sitaxentan—Diarrhoea—Irinotecan—colon cancer	0.000467	0.000639	CcSEcCtD
Sitaxentan—Dry mouth—Capecitabine—colon cancer	0.000466	0.000638	CcSEcCtD
Sitaxentan—Dizziness—Vincristine—colon cancer	0.000463	0.000635	CcSEcCtD
Sitaxentan—Visual impairment—Methotrexate—colon cancer	0.000461	0.000632	CcSEcCtD
Sitaxentan—Confusional state—Capecitabine—colon cancer	0.00046	0.000631	CcSEcCtD
Sitaxentan—Oedema—Capecitabine—colon cancer	0.000456	0.000625	CcSEcCtD
Sitaxentan—Infection—Capecitabine—colon cancer	0.000453	0.000621	CcSEcCtD
Sitaxentan—Dizziness—Irinotecan—colon cancer	0.000451	0.000618	CcSEcCtD
Sitaxentan—Nervous system disorder—Capecitabine—colon cancer	0.000448	0.000613	CcSEcCtD
Sitaxentan—Eye disorder—Methotrexate—colon cancer	0.000447	0.000612	CcSEcCtD
Sitaxentan—Diarrhoea—Fluorouracil—colon cancer	0.000447	0.000612	CcSEcCtD
Sitaxentan—Thrombocytopenia—Capecitabine—colon cancer	0.000447	0.000612	CcSEcCtD
Sitaxentan—Tinnitus—Methotrexate—colon cancer	0.000446	0.000611	CcSEcCtD
Sitaxentan—Tachycardia—Capecitabine—colon cancer	0.000445	0.00061	CcSEcCtD
Sitaxentan—Vomiting—Vincristine—colon cancer	0.000445	0.00061	CcSEcCtD
Sitaxentan—Cardiac disorder—Methotrexate—colon cancer	0.000444	0.000608	CcSEcCtD
Sitaxentan—Skin disorder—Capecitabine—colon cancer	0.000443	0.000607	CcSEcCtD
Sitaxentan—Rash—Vincristine—colon cancer	0.000442	0.000605	CcSEcCtD
Sitaxentan—Dermatitis—Vincristine—colon cancer	0.000441	0.000604	CcSEcCtD
Sitaxentan—Headache—Vincristine—colon cancer	0.000439	0.000601	CcSEcCtD
Sitaxentan—Anorexia—Capecitabine—colon cancer	0.000435	0.000596	CcSEcCtD
Sitaxentan—Angiopathy—Methotrexate—colon cancer	0.000434	0.000595	CcSEcCtD
Sitaxentan—Vomiting—Irinotecan—colon cancer	0.000434	0.000594	CcSEcCtD
Sitaxentan—Immune system disorder—Methotrexate—colon cancer	0.000432	0.000592	CcSEcCtD
Sitaxentan—Dizziness—Fluorouracil—colon cancer	0.000432	0.000592	CcSEcCtD
Sitaxentan—Mediastinal disorder—Methotrexate—colon cancer	0.000431	0.000591	CcSEcCtD
Sitaxentan—Rash—Irinotecan—colon cancer	0.00043	0.000589	CcSEcCtD
Sitaxentan—Dermatitis—Irinotecan—colon cancer	0.00043	0.000589	CcSEcCtD
Sitaxentan—Headache—Irinotecan—colon cancer	0.000427	0.000585	CcSEcCtD
Sitaxentan—Hypotension—Capecitabine—colon cancer	0.000427	0.000584	CcSEcCtD
Sitaxentan—Alopecia—Methotrexate—colon cancer	0.000423	0.000579	CcSEcCtD
Sitaxentan—Mental disorder—Methotrexate—colon cancer	0.000419	0.000574	CcSEcCtD
Sitaxentan—Malnutrition—Methotrexate—colon cancer	0.000416	0.00057	CcSEcCtD
Sitaxentan—Nausea—Vincristine—colon cancer	0.000416	0.00057	CcSEcCtD
Sitaxentan—Vomiting—Fluorouracil—colon cancer	0.000415	0.000569	CcSEcCtD
Sitaxentan—Insomnia—Capecitabine—colon cancer	0.000413	0.000566	CcSEcCtD
Sitaxentan—Rash—Fluorouracil—colon cancer	0.000412	0.000564	CcSEcCtD
Sitaxentan—Dermatitis—Fluorouracil—colon cancer	0.000411	0.000564	CcSEcCtD
Sitaxentan—Headache—Fluorouracil—colon cancer	0.000409	0.000561	CcSEcCtD
Sitaxentan—Nausea—Irinotecan—colon cancer	0.000405	0.000555	CcSEcCtD
Sitaxentan—Dyspepsia—Capecitabine—colon cancer	0.000402	0.000551	CcSEcCtD
Sitaxentan—Decreased appetite—Capecitabine—colon cancer	0.000397	0.000544	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Capecitabine—colon cancer	0.000394	0.00054	CcSEcCtD
Sitaxentan—Fatigue—Capecitabine—colon cancer	0.000394	0.000539	CcSEcCtD
Sitaxentan—Pain—Capecitabine—colon cancer	0.00039	0.000535	CcSEcCtD
Sitaxentan—Constipation—Capecitabine—colon cancer	0.00039	0.000535	CcSEcCtD
Sitaxentan—Nausea—Fluorouracil—colon cancer	0.000388	0.000532	CcSEcCtD
Sitaxentan—Ill-defined disorder—Methotrexate—colon cancer	0.000386	0.000529	CcSEcCtD
Sitaxentan—Anaemia—Methotrexate—colon cancer	0.000385	0.000527	CcSEcCtD
Sitaxentan—Feeling abnormal—Capecitabine—colon cancer	0.000376	0.000515	CcSEcCtD
Sitaxentan—Malaise—Methotrexate—colon cancer	0.000375	0.000514	CcSEcCtD
Sitaxentan—Vertigo—Methotrexate—colon cancer	0.000374	0.000513	CcSEcCtD
Sitaxentan—Leukopenia—Methotrexate—colon cancer	0.000373	0.000511	CcSEcCtD
Sitaxentan—Urticaria—Capecitabine—colon cancer	0.000363	0.000497	CcSEcCtD
Sitaxentan—Body temperature increased—Capecitabine—colon cancer	0.000361	0.000494	CcSEcCtD
Sitaxentan—Chest pain—Methotrexate—colon cancer	0.000354	0.000486	CcSEcCtD
Sitaxentan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000352	0.000482	CcSEcCtD
Sitaxentan—Discomfort—Methotrexate—colon cancer	0.00035	0.00048	CcSEcCtD
Sitaxentan—Confusional state—Methotrexate—colon cancer	0.000343	0.000469	CcSEcCtD
Sitaxentan—Infection—Methotrexate—colon cancer	0.000338	0.000463	CcSEcCtD
Sitaxentan—Hypersensitivity—Capecitabine—colon cancer	0.000336	0.000461	CcSEcCtD
Sitaxentan—Nervous system disorder—Methotrexate—colon cancer	0.000333	0.000457	CcSEcCtD
Sitaxentan—Thrombocytopenia—Methotrexate—colon cancer	0.000333	0.000456	CcSEcCtD
Sitaxentan—Skin disorder—Methotrexate—colon cancer	0.00033	0.000452	CcSEcCtD
Sitaxentan—Asthenia—Capecitabine—colon cancer	0.000327	0.000449	CcSEcCtD
Sitaxentan—Anorexia—Methotrexate—colon cancer	0.000324	0.000444	CcSEcCtD
Sitaxentan—Hypotension—Methotrexate—colon cancer	0.000318	0.000435	CcSEcCtD
Sitaxentan—Diarrhoea—Capecitabine—colon cancer	0.000312	0.000428	CcSEcCtD
Sitaxentan—Insomnia—Methotrexate—colon cancer	0.000307	0.000421	CcSEcCtD
Sitaxentan—Somnolence—Methotrexate—colon cancer	0.000302	0.000414	CcSEcCtD
Sitaxentan—Dizziness—Capecitabine—colon cancer	0.000302	0.000414	CcSEcCtD
Sitaxentan—Dyspepsia—Methotrexate—colon cancer	0.000299	0.00041	CcSEcCtD
Sitaxentan—Decreased appetite—Methotrexate—colon cancer	0.000295	0.000405	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Methotrexate—colon cancer	0.000293	0.000402	CcSEcCtD
Sitaxentan—Fatigue—Methotrexate—colon cancer	0.000293	0.000401	CcSEcCtD
Sitaxentan—Pain—Methotrexate—colon cancer	0.000291	0.000398	CcSEcCtD
Sitaxentan—Vomiting—Capecitabine—colon cancer	0.00029	0.000398	CcSEcCtD
Sitaxentan—Rash—Capecitabine—colon cancer	0.000288	0.000394	CcSEcCtD
Sitaxentan—Dermatitis—Capecitabine—colon cancer	0.000288	0.000394	CcSEcCtD
Sitaxentan—Headache—Capecitabine—colon cancer	0.000286	0.000392	CcSEcCtD
Sitaxentan—Feeling abnormal—Methotrexate—colon cancer	0.00028	0.000384	CcSEcCtD
Sitaxentan—Nausea—Capecitabine—colon cancer	0.000271	0.000371	CcSEcCtD
Sitaxentan—Urticaria—Methotrexate—colon cancer	0.00027	0.00037	CcSEcCtD
Sitaxentan—Body temperature increased—Methotrexate—colon cancer	0.000269	0.000368	CcSEcCtD
Sitaxentan—Hypersensitivity—Methotrexate—colon cancer	0.00025	0.000343	CcSEcCtD
Sitaxentan—Asthenia—Methotrexate—colon cancer	0.000244	0.000334	CcSEcCtD
Sitaxentan—Diarrhoea—Methotrexate—colon cancer	0.000232	0.000319	CcSEcCtD
Sitaxentan—Dizziness—Methotrexate—colon cancer	0.000225	0.000308	CcSEcCtD
Sitaxentan—Vomiting—Methotrexate—colon cancer	0.000216	0.000296	CcSEcCtD
Sitaxentan—Rash—Methotrexate—colon cancer	0.000214	0.000294	CcSEcCtD
Sitaxentan—Dermatitis—Methotrexate—colon cancer	0.000214	0.000293	CcSEcCtD
Sitaxentan—Headache—Methotrexate—colon cancer	0.000213	0.000292	CcSEcCtD
Sitaxentan—Nausea—Methotrexate—colon cancer	0.000202	0.000277	CcSEcCtD
